Benefits of drinking water for kidneys: If you don't drink enough water, it's your kidneys — the natural filtering system for the body — that pay a heavy price. Chronic dehydration can cause stones, infections, hypertension and kidney failure. Here's how to stay safe.
Kidneys help to filter waste, balance fluids, and regulate blood pressure. But like many organs, they can face silent threats, including cancer risk. Kidney cancer is often detected during unrelated health checks and may show no early symptoms. Here are the warning signs, how it’s diagnosed, the various stages, the range of treatments available, and preventive tips.
Urinary tract infections are common in women, but frequent episodes could pose more than temporary discomfort. Uncover how recurrent UTIs may raise the risk of kidney cancer, what symptoms to watch for, and what proactive steps women can take to stay safe and maintain urinary health.
Kidney cancer rates are rising and everyday habits may be fuelling the risk without most people even knowing it. From diet to painkillers and even your job, small choices can have a lasting impact on kidney health. Here's how to protect yourself.
Kidney cancer: Understanding the symptoms and embracing preventive measures for kidney cancer can significantly impact your overall health. Here are several signs and symptoms that may suggest the presence of this disease. Adopting a healthy lifestyle and regular checkups can go a long way in preventing this potentially serious condition.
German drugmaker Bayer may be fighting it out in the courtroom to defend its patent rights on cancer drug Nexavar. But out in the market, it's already lost considerable market share to cheaper variants from Cipla and Natco.
By granting compulsory license to Natco for Bayer's kidney cancer drug Nexavar, the Indian government has opened a legal can of worms, reports CNBC-TV18's Archana Shukla.
Compulsory license granted to Natco has left the Indian pharma industry with a hard choice to make - cut prices, or quit selling the drug. To counter this drug-makers are changing strategies, reports CNBC-TV18's Archana Shukla.
GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of GlaxoSmithKline PLC today announced the launch of two drugs in India - Revolade and Votrient.